Published in Curr HIV/AIDS Rep on June 01, 2013
Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention. AIDS Res Hum Retroviruses (2014) 0.96
Incentivizing HIV/STI testing: a systematic review of the literature. AIDS Behav (2014) 0.96
Systematic review of strategies to increase men's HIV-testing in sub-Saharan Africa. AIDS (2014) 0.95
Heterogeneous HIV testing preferences in an urban setting in Tanzania: results from a discrete choice experiment. PLoS One (2014) 0.85
Biomedical research, a tool to address the health issues that affect African populations. Global Health (2013) 0.83
Characteristics of sexually experienced HIV testers aged 18 to 32 in rural South Africa: baseline results from a community-based trial, NIMH Project Accept (HPTN 043). BMC Public Health (2014) 0.83
Potential barriers to rapid testing for human immunodeficiency virus among a commuter population in Johannesburg, South Africa. HIV AIDS (Auckl) (2014) 0.79
Using a Cultural Framework to Understand Factors Influencing HIV Testing in Nigeria. Int Q Community Health Educ (2016) 0.78
Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community. J Int AIDS Soc (2015) 0.76
HIV-1 DIS stem loop forms an obligatory bent kissing intermediate in the dimerization pathway. Nucleic Acids Res (2014) 0.76
Estimated HIV incidence in the United States, 2006-2009. PLoS One (2011) 13.03
Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS (2006) 9.45
Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet (2002) 5.80
Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med (2013) 5.39
Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet (2006) 5.34
Risk factors for recent HIV infection in Uganda. JAMA (2008) 4.84
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet (2008) 4.70
Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS (2007) 4.52
The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS (2009) 4.45
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet (2009) 4.33
Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet (2004) 4.19
Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol (2004) 3.92
Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med (2006) 3.80
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health (2007) 3.69
Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One (2009) 3.66
HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey. AIDS (2008) 3.52
Unfinished business--expanding HIV testing in developing countries. N Engl J Med (2006) 3.48
Tobacco product use among adults--United States, 2012-2013. MMWR Morb Mortal Wkly Rep (2014) 3.46
Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings. J Acquir Immune Defic Syndr (2006) 3.38
Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav (2006) 3.18
Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr (2010) 2.83
Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals. Bull World Health Organ (2008) 2.80
Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. AIDS Behav (2007) 2.78
Routine intrapartum HIV counseling and testing for prevention of mother-to-child transmission of HIV in a rural Ugandan hospital. J Acquir Immune Defic Syndr (2006) 2.67
Desire for children and pregnancy risk behavior among HIV-infected men and women in Uganda. AIDS Behav (2006) 2.59
Home-based model for HIV voluntary counselling and testing. Lancet (2003) 2.57
HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA (2006) 2.51
Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. AIDS (2005) 2.50
Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int (2008) 2.49
CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 2.32
Notes from the field: calls to poison centers for exposures to electronic cigarettes--United States, September 2010-February 2014. MMWR Morb Mortal Wkly Rep (2014) 2.18
Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr (2012) 2.15
Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda. Am J Trop Med Hyg (2005) 2.12
Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One (2010) 2.12
Lack of knowledge of HIV status a major barrier to HIV prevention, care and treatment efforts in Kenya: results from a nationally representative study. PLoS One (2012) 2.10
Estimating per-act HIV transmission risk: a systematic review. AIDS (2014) 2.04
Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav (2006) 2.01
Ebola virus disease in health care workers--Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.99
Home-based HIV testing and counseling in rural and urban Kenyan communities. J Acquir Immune Defic Syndr (2013) 1.98
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr (2007) 1.97
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ (2011) 1.96
The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Appl Health Econ Health Policy (2009) 1.94
Prevention of mother-to-child transmission and voluntary counseling and testing programme data: what is their utility for HIV surveillance? AIDS (2005) 1.80
Factors associated with HIV infection in married or cohabitating couples in Kenya: results from a nationally representative study. PLoS One (2011) 1.68
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis. Bull World Health Organ (2011) 1.61
Sexual risk behaviour and viral suppression among HIV-infected adults receiving medical care in the United States. AIDS (2014) 1.61
Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses. J Acquir Immune Defic Syndr (2005) 1.59
Epidemiology of HIV in the United States. J Acquir Immune Defic Syndr (2010) 1.58
Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PLoS One (2011) 1.56
Home-based antiretroviral care is associated with positive social outcomes in a prospective cohort in Uganda. J Acquir Immune Defic Syndr (2007) 1.52
Use of a nationwide call center for Ebola response and monitoring during a 3-day house-to-house campaign - Sierra Leone, September 2014. MMWR Morb Mortal Wkly Rep (2015) 1.52
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr (2008) 1.51
A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States. J Acquir Immune Defic Syndr (2010) 1.48
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis (2012) 1.45
Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality. J Infect Dis (2012) 1.42
Improving burial practices and cemetery management during an Ebola virus disease epidemic - Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep (2015) 1.39
'Pregnancy comes accidentally--like it did with me': reproductive decisions among women on ART and their partners in rural Uganda. BMC Public Health (2011) 1.38
Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr (2010) 1.38
Couples at risk: HIV-1 concordance and discordance among sexual partners receiving voluntary counseling and testing in Uganda. J Acquir Immune Defic Syndr (2005) 1.36
Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr (2006) 1.35
The estimated burden of HIV/AIDS in Uganda, 2005-2010. AIDS (2008) 1.34
State laws prohibiting sales to minors and indoor use of electronic nicotine delivery systems--United States, November 2014. MMWR Morb Mortal Wkly Rep (2014) 1.33
Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States. J Acquir Immune Defic Syndr (2014) 1.33
HIV infection and older Americans: the public health perspective. Am J Public Health (2012) 1.31
Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index. AIDS Res Ther (2007) 1.30
Rapid assessment of Ebola infection prevention and control needs--six districts, Sierra Leone, October 2014. MMWR Morb Mortal Wkly Rep (2014) 1.30
Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr (2006) 1.29
Coming back from the dead: living with HIV as a chronic condition in rural Africa. Health Policy Plan (2007) 1.29
Using the HIV surveillance system to monitor the National HIV/AIDS Strategy. Am J Public Health (2012) 1.27
Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS (2011) 1.25
Trends in HIV prevalence and HIV testing among young MSM: five United States cities, 1994-2011. AIDS Behav (2014) 1.22
Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr (2011) 1.21
Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. J Acquir Immune Defic Syndr (2007) 1.20
Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. Am J Trop Med Hyg (2006) 1.20
Correlates of HIV Infection Among Sexually Active Adults in Kenya: A National Population-Based Survey. Open AIDS J (2011) 1.19
Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness. PLoS One (2012) 1.18